Candriam Equities L Oncology Impact C
LU1864484214
Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV1/23/2025 |
Chg.+2.5400 |
Type of yield |
Investment Focus |
Investment company |
| 238.7100EUR |
+1.08% |
reinvestment |
Equity
Worldwide
|
Candriam ▶ |
Investment strategy
Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
The fund seeks to achieve capital growth by investing in the principal assets traded and to outperform the benchmark while also generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer. The management team makes discretionary investment choices based on economic/financial analyses, but also on the basis of Candriam's internal analysis of environmental, social and governance (ESG) criteria.
Investment goal
Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
Master data
| Type of yield: |
reinvestment |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Health / Pharma |
| Benchmark: |
MSCI World (Net Return) |
| Business year start: |
1/1 |
| Last Distribution: |
- |
| Depository bank: |
CACEIS Bank, Luxembourg Branch |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Austria, Germany, Switzerland, Czech Republic |
| Fund manager: |
Rudi Van Den Eynde, Linden Thomson |
| Fund volume: |
1.89 bill.
USD
|
| Launch date: |
4/25/2019 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
3.50% |
| Max. Administration Fee: |
1.60% |
| Minimum investment: |
0.00 EUR |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Candriam |
| Address: |
19-21 route d'Arlon, 8009, Strassen |
| Country: |
Luxembourg |
| Internet: |
www.candriam.com
|
Assets
| Stocks |
|
96.74% |
| Cash |
|
2.75% |
| Others |
|
0.51% |
Countries
| United States of America |
|
57.17% |
| Switzerland |
|
11.53% |
| Germany |
|
8.29% |
| Denmark |
|
6.57% |
| United Kingdom |
|
5.04% |
| Japan |
|
2.83% |
| Cash |
|
2.75% |
| Cayman Islands |
|
2.24% |
| Netherlands |
|
1.25% |
| Ireland |
|
1.20% |
| China |
|
0.62% |
| Others |
|
0.51% |
Branches
| Pharma/Biotechnology |
|
71.34% |
| Healthcare services |
|
15.04% |
| Healthcare appliances |
|
10.36% |
| Cash |
|
2.75% |
| Others |
|
0.51% |